Copenhagen, [9] November 2012 – Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL), a Danish biotechnology company dedicated to the discovery and development of novel peptide drugs, will announce its Interim Report for the first nine months of 2012 on Tuesday, 13 November 2012.
